ElevateBio

📍 Waltham, United States👥 452 employees💰 Last funded Jun 2026
Pharmaceutical Manufacturing🌐 elevate.bio
Website LinkedIn
ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization. Combining proprietary gene editing tools and services, cGMP manufacturing capabilities, and industry-leading expertise, ElevateBio is enabling partners advance a breadth of therapeutic approaches and modalities including cell therapies, gene edited therapies, RNA therapies, mRNA vaccines, and more.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2021–2026 · investors recorded per year
202112023120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in ElevateBio?
ElevateBio has 3 investors on record on gritt.io.
When did ElevateBio last raise funding?
The most recent investment in ElevateBio recorded on gritt.io was in June 2026.
What industry is ElevateBio in?
ElevateBio operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is ElevateBio based?
ElevateBio is headquartered in Waltham, United States.